Guided by our key cultural value of Courageous CaringTM and
driven by a sense of urgency, we are building an innovative
biopharma company that invests in, develops and
commercializes life-changing drug therapies.

See Our Advantage


Dr. Shao-Lee Lin and Bob Carey talk strategy and more at ACELYRIN
March 24, 2021

We recently sat down with ACELYRIN CEO Shao-Lee Lin, MD, PhD and President and COO Bob Carey to talk about the company’s strategy, upcoming milestones, and its intense focus on patients.

Courageous Caring
in the Age of COVID
March 4, 2021

Throughout her career, Shao-Lee Lin, MD, PhD has always been driven by a personal mission to make a meaningful difference in patients’ lives.

ACELYRIN Launches with Funding from Westlake Village BioPartners
December 15, 2020

Company founders Shao-Lee Lin, MD, PhD, and Bob Carey have proven track records of building multibillion-dollar medicines